Download PDF
Synfacts 2017; 13(07): 0678
DOI: 10.1055/s-0036-1590520
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Artemisinin

Contributor(s):
Philip Kocienski
Cherry J. * Kumar A. * et al. Ipca Laboratories Limited, Mumbai, India and Amyris Inc., Emeryville, USA
Amalgamation of Synthetic Biology and Chemistry for High-Throughput Nonconventional Synthesis of the Antimalarial Drug Artemisinin.

Org. Process Res. Dev. 2017;
21: 551-558
CrossrefGoogle Scholar
Further Information

Publication History

Publication Date:
19 June 2017 (online)

 
 PDF Download Permissions and Reprints

Key words

artemisinin - malaria - amorpha-4,11-diene - dihydroartemisinic acid

Significance

Artemisinin is extracted from the Chinese medicinal plant Artemisia annua and is used in combination therapy for the treatment of malaria. To date, extraction and total synthesis have failed to address the problems of high cost and erratic supply of artemisinin. Amorpha-4,11-diene (A) is a biogenetic precursor of artemisinin that can be generated in titers of more than 120 g/L using an engineered yeast strain containing the requisite Artemisia annua genes coupled with an upregulated terpene pathway. The scheme depicts a nine-step conversion of A into artemisinin in 30% overall yield.


#

Comment

The strategy for converting the amorpha-4,11-diene into artemisinin via key intermediate (11R)-dihydroartemisinic acid required the selective functionalization of the exocyclic alkene. Because this was not possible, the more reactive endocyclic alkene was selectively protected as epoxide B. After side-chain manipulation, the epoxide deprotection (G → H) was accomplished by reductive elimination using lithium biphenylide – a step that may be challenging on scale.


#
#


   Permissions and Reprints